Merck gives Moderna $ 250 million for cancer mRNA vaccine
The drug company could "cash in on" the mRNA cancer vaccine it is helping to deliver.
Read moreThe drug company could "cash in on" the mRNA cancer vaccine it is helping to deliver.
Read moreIn a video call with investors, Moderna warns of new waves coming for Covid-19
Read moreTo submit articles, disclose the results of a research or scientific discoveries write to the editorial staff
Futuroprossimo.it provides news on the future of technology, science and innovation: if there is something that is about to arrive, here it has already arrived. FuturoProssimo is part of the network ForwardTo, studies and skills for future scenarios.
© 2022 Near future -
This work is distributed under license Creative Commons Attribution 4.0 International.